Articles published in 2017 in this theme: 1 (scroll down to load remaining articles)
2017
![Assessing the Efficacy and Safety of an 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) in the Idiopathic Intracranial Hypertension Drug Trial, IIH:DT: Clinical Methods and Design for a Phase II Randomized Controlled Trial Assessing the Efficacy and Safety of an 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) in the Idiopathic Intracranial Hypertension Drug Trial, IIH:DT: Clinical Methods and Design for a Phase II Randomized Controlled Trial](https://asset.jmir.pub/assets/thumbs/f6c51732725ee4fcd8a639af8c4eaeaa.png 480w,https://asset.jmir.pub/assets/thumbs/f6c51732725ee4fcd8a639af8c4eaeaa.png 960w,https://asset.jmir.pub/assets/thumbs/f6c51732725ee4fcd8a639af8c4eaeaa.png 1920w,https://asset.jmir.pub/assets/thumbs/f6c51732725ee4fcd8a639af8c4eaeaa.png 2500w)
Keira Annie Markey, Ryan Ottridge, James L Mitchell, Caroline Rick, Rebecca Woolley, Natalie Ives, Peter Nightingale, Alexandra J Sinclair
JMIR Res Protoc 2017 (Sep 18); 6(9):e181Download Citation: END BibTex RIS